Doses of rituximab for retreatment in rheumatoid arthritis: Influence on maintenance and risk of serious infection
Rheumatology Dec 22, 2017
Henry J, et al. - This study was implemented to examine maintenance of rituximab (RTX) in RA patients re-treated with reduced doses vs standard dose in a real life setting. Retreatment with reduced doses of RTX had no impact on the maintenance of RTX at 5 years but permitted a 39% total dose reduction and a lower rate of serious infections.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
